Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency VirusFrédérique Chammartin, Amanda Mocroft, Alexander Egle et al.|Clinical Infectious Diseases|2023Cited by 27
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort SettingLauren Greenberg, A Tavelli, Huldrych F. Günthard et al.|Open Forum Infectious Diseases|2022Cited by 5
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of viewAntonella Cingolani, Stefano Bonora, A Tavelli et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 2
OC-50 Implementation of PrEP in Italy: results of PrIDE surveySilvia Nozza, A Antinori, Valentina Mazzotta et al.|Unknown|2024Cited by 1